Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. 2005N-0149]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of 16 new animal drug applications (NADAs) and 1 abbreviated NADA (ANADA) because the products are no longer manufactured or marketed.  In a final rule published elsewhere in this issue of the 
                        **Federal Register**
                        , FDA is amending the animal drug regulations to remove portions reflecting approval of the NADAs.
 DATES: Withdrawal of approval is effective September 6, 2005.
 FOR FURTHER INFORMATION CONTACT: Pamela K. Esposito, Center for Veterinary Medicine (HFV-210), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-7818, or e-mail: 
                        *pesposit@cvm.fda.gov*.


SUPPLEMENTARY INFORMATION: The following sponsors have requested that FDA withdraw approval of the 16 NADAs and 1 ANADA listed in table 1 of this document because the products are no longer manufactured or marketed: 
 
 **Table 1.**
Sponsor
NADA Number, Product (Drug)
21 CFR Section Affected, (Sponsor Drug Labeler Code)Abbott Laboratories, North Chicago, IL 60064
NADA 99-568, FURANACE Caps (nifurpirinol)
529.1526 (000074)Biocraft Laboratories, Inc., 92 Route 46, Elmwood Park, NJ  07407
NADA 140-889, DERM-OTIC Ointment (neomycin sulfate, nystatin, thiostrepton, triamcinolone acetonide)
524.1600a (000332)First Priority, Inc., 1585 Todd Farm Dr., Elgin, IL  60123
NADA 48-646, THERAZONE Injection (phenylbutazone)
522.1720 (058829)Happy Jack, Inc., Snow Hill, NC  28580
NADA 121-556, Selenium Sulfide Suspension (selenium disulfide)
524.2101 (023851)NADA 121-723, Nitrofurazone Dressing
524.1580b (023851)NADA 125-137, FILARICIDE Capsules (diethylcarbamazine citrate)
520.622d (023851)IMPAX Laboratories, Inc., 30831 Huntwood Ave., Hayward, CA 94544
NADA 92-151, N-Butyl Chloride Canine Worming Caps
520.260 (000115)NADA 65-065, Tetracycline HCl Caps
520.2345a (000115)NADA 138-900, Dichlorophene/Toluene
520.580 (000115)Jorgensen Laboratories, Inc., 1450 North Van Buren Ave., Loveland, CO  80538
NADA 10-481, SUREJETS (salacylic acid)
529.2090 (048087)Pliva d.d., Ulica grada Vukovara 49, 10000 Zagreb, Croatia
ANADA, 200-232, GEOMYCIN 200 Injection (oxytetracycline)
522.1660a (011722)Purina Mills, Inc., P.O. Box 66812, St. Louis, MO  63166-6812
NADA 65-113 AUREO Sulfa Soluble Powder (chlortetracycline/sulfamethazine)
N/A (017800)Roche Vitamins, Inc., 45 Waterview Blvd., Parsippany, NJ  07054-1298
NADA 140-848, VETEEZE Injection (diazepam)
522.575 (063238)Teva Pharmaceuticals USA, 650 Cathill Rd., Sellersville, PA  18960
NADA 131-806, Furosemide Tablets
520.1010 (000093)Virbac AH, Inc., 3200 Meacham Blvd., Ft. Worth, TX 76137
NADA 10-886, Purina Liquid Wormer (piperazine citrate)
N/A (051311)Wyeth Laboratories, Division of American Home Products Corp., P.O. Box 8299, Philadelphia, PA 19101
NADA 10-782, SPARINE Injection (promazine)
522.1962 (000008)NADA 55-008, BICILLIN Fortified (penicillin G benzathine and penicillin G procaine)
522.1696a (000008)
 Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10), redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with § 514.115 
                    *Withdrawal of approval of applications*
                     (21 CFR 514.115), notice is given that approval of NADAs 10-481, 10-782, 10-886, 48-646, 55-008, 65-065, 65-113, 99-568, 121-556, 121-723, 125-137, 131-806, 138-900, 140-848, 140-889, and ANADA 200-232, and all supplements and amendments thereto, is hereby withdrawn, effective September 6, 2005. In a final rule published elsewhere in this issue of the 
                    **Federal Register**
                    , FDA is amending the animal drug regulations to reflect the withdrawal of approval of these NADAs. Dated: July 5, 2005. Linda Tollefson, Acting Director, Center for Veterinary Medicine.


[FR Doc. 05-16994 Filed 8-25-05; 8:45 am] BILLING CODE 4160-01-S